Horan Capital Management’s Gilead Sciences GILD Stock Holding History

Horan Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-265,477	Closed	-$18.8M	–	65
2018 Q2	$18.8M	Sell	265,477 -12,264	-4%	-$866K	3.68%	9
2018 Q1	$20.9M	Buy	277,741 +4,063	+1%	+$323K	4.54%	8
2017 Q4	$19.6M	Sell	273,678 -4,587	-2%	-$348K	3.89%	10
2017 Q3	$22.5M	Sell	278,265 -1,469	-0.5%	-$112K	4.68%	5
2017 Q2	$19.8M	Buy	279,734 +28,734	+11%	+$1.91M	4.33%	6
2017 Q1	$17M	Buy	251,000 +68,600	+38%	+$4.82M	3.88%	8
2016 Q4	$13.1M	Buy	182,400 +73,111	+67%	+$5.43M	3.38%	14
2016 Q3	$8.65M	Buy	109,289 +44,432	+69%	+$3.61M	2.29%	19
2016 Q2	$5.41M	Buy	64,857 +41,796	+181%	+$3.71M	1.5%	27
2016 Q1	$2.12M	Buy	+23,061	New	+$2.08M	0.59%	40

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Horan Capital Management's GILD Position: Q3 2018 in Review

Horan Capital Management sold out of Gilead Sciences (GILD) in Q3 2018, closing a stake of 265,477 shares — an estimated $18.8M sold.

Horan Capital Management first reported a position in GILD in Q1 2016 and held it in 10 quarters. The position peaked at $22.5M in Q3 2017. 1,528 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

Horan Capital Management reported no remaining Gilead Sciences position as of Q3 2018 after selling out during the quarter.
Horan Capital Management sold 265,477 Gilead Sciences shares in Q3 2018, an estimated $18.8M.
Horan Capital Management first reported a position in Gilead Sciences in Q1 2016 and held it in 10 quarters.
Horan Capital Management's Gilead Sciences position peaked at $22.5M in Q3 2017.
1,528 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on Horan Capital Management's 13F filing for Q3 2018, filed 26 Oct 2018.